Results 181 to 190 of about 519,396 (228)

Disproportionality Analysis of Adverse Events Associated with IL-1 Inhibitors in the FDA Adverse Event Reporting System (FAERS). [PDF]

Pharmaceuticals (Basel)
Lei J, Lou Z, Jiang Y, Cui Y, Li S, Hu J, Jing Y, Yang J.   +7 more
europepmc   +1 more source

Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS (FDA Adverse Event Reporting System) Database

Miranda Murray, Fabrizio Schifano, Stefania Chiappini, John Corkery, Amira Guirguis   +4 more
openalex   +1 more source

Osimertinib-related myotoxicity: a disproportionality analysis of the FDA adverse event reporting system. [PDF]

BMC Cancer
Tan Y, Song Q.
europepmc   +1 more source

A real-world data analysis of piroxicam in the FDA Adverse Event Reporting System (FAERS) database. [PDF]

Front Med (Lausanne)
Wang Y, Kong Q.
europepmc   +1 more source

A real-world disproportionality analysis of roflumilast using the US food and drug administration adverse event reporting system data. [PDF]

Front Drug Saf Regul
Huang B, Ma Y, Wang W, Gu S, Wang X.
europepmc   +1 more source

Prescriptions for Excellence in Health Care Spring 2010 Dowload Full PDF [PDF]

, 2010

core   +1 more source

Hepatotoxicity associated with anti-neoplastic agents: a pharmacovigilance analysis of the Food and Drug Administration Adverse Event Reporting System database. [PDF]

Front Immunol
Shi L, Wang Y, Qu Y, Chen R.
europepmc   +1 more source

Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Charles Khouri, Alex Hlavaty, Bruno Revol, Francesco Salvo, Emanuel Raschi   +4 more
openalex   +1 more source

Real-world safety of Symdeko: insights from the food and drug administration adverse event reporting system. [PDF]

Front Med (Lausanne)
Wei S, Zhang L, Liu C, Qi X.
europepmc   +1 more source